We’re proud to celebrate #BastilleDay and honor Servier’s French heritage. Happy French-American Heritage Month! Discover more about our company’s history: https://ow.ly/nGhw50SAHIP
About us
Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to serve patient needs and strives to provide future generations with a world where quality healthcare is available and accessible to all. See our community guidelines here: https://www.servier.us/community-guidelines To report a suspected adverse event with a Servier product, please visit: https://www.servier.us/contact-us
- Website
-
https://www.servier.us/
External link for Servier Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Boston , MA
- Type
- Nonprofit
Locations
-
Primary
Get directions
200 Pier Four Boulevard
Boston , MA 02210, US
Employees at Servier Pharmaceuticals
Updates
-
Facing a glioma diagnosis can be challenging. Discover essential tools and resources at My Glioma Guide to support you through this journey: https://ow.ly/k53E50SyO1N
-
Our team hosted an insightful moderated discussion on the importance of sustaining Diversity, Equity, and Inclusion (DEI) initiatives in the workplace, within the life sciences community, with patients, and with partners. Our conversation shed light on what DEI and health equity means for different employee and patient populations and how we can better support them. Thank you to our speakers! Scout: Executive Director of National LGBTQI+ Cancer Network Tom Browne: Head of DEI Initiatives and Programming for MassBio Fernando Adriano: Senior Oncology Consultant for Servier NE Region and Registered Nurse
-
-
Phase 1 data for our treatment in patients in China with IDH-mutant acute myeloid leukemia (AML) was recently published in Blood Science, the journal of the American Society of Hematology. These results demonstrated consistent safety and clinical benefits in this challenging and hard-to-treat cancer. Read more: https://lnkd.in/g9RjGXr5
-
The signs and symptoms of glioma are not the same for everyone, varying based on the size and location of the tumor. Learn more about the common symptoms and manifestations of glioma here: https://lnkd.in/gWZ8P7bM
-
-
We are excited to announce that POLARIS, our innovative project to enhance communication for acute lymphoblastic leukaemia (ALL) treatment, has been named a finalist for the Langland Award for Excellence in Healthcare Partnership! POLARIS was a collaborative development between Servier, SIOP Europe, the European Society for Paediatric Oncology (SIOPE), CCI Europe, Syneos Health France and the Velella Group, that provides clear, accessible treatment roadmaps and personalized web-based support, helping families track treatments in real-time and in their native languages. Thank you to our partners and to the Communique Awards for this recognition! We remain committed to empowering families and improving the ALL treatment journey. https://lnkd.in/eBXu_t6f #HealthcareExcellence #AwardWinning #HealthcarePartnership #PatientCentric #InnovationInHealthcare #Servier #SyneosHealth
Finalists 2024
https://communiqueawards.com
-
Last call for submissions! Startups developing innovative approaches in oncology, neuroscience small molecule modalities or AI/ML data-driven platforms, make sure you submit your applications for Servier’s 2024 FAST Discovery Award in partnership with California Life Sciences (CLS)! Apply by July 1 for the chance to win a spot in the CLS FAST Fall cohort – a program that matches entrepreneurs with a custom team of advisors for an intensive team review. Go here for full submission details – https://lnkd.in/g3mWqMxx
-
-
We are #movedbyscience and work tirelessly to bring the promise of tomorrow to the patients we serve. Through our continuously growing oncology pipeline, we aim to bring the power of drug discovery and development to the forefront to help more patients impacted by cancer. Learn more about our efforts: https://lnkd.in/esSSHFz3
-
Thank you, Authority Magazine, for recognizing Walid Kamoun and the work that we do to bring groundbreaking treatments to patients in need worldwide. At Servier, we are focused on creating a culture of innovation, while harnessing the power of drug research and development to help address some of today’s greatest scientific challenges. Check out the full article below!
Recently, I had the pleasure of speaking with Authority Magazine to discuss my career journey and the work we do at Servier to help bring breakthrough cancer treatments to the patient communities we serve. Through Servier’s One Innovation Engine, we relentlessly pursue strategies that accelerate drug research and development to deliver for patients in areas with great unmet need. To do this, we understand that it takes constant collaboration and innovative thinking across the industry. Read more about Servier’s recent innovations in oncology and our continued work to bring new therapies to patients worldwide: https://lnkd.in/e7gdH7bs #ServierOncology #TransformativeMedicines
Innovation vs Bureaucracy: Walid S Kamoun Of Servier On Strategies for Fostering Innovation Inside…
medium.com
-
When confronted with a glioma diagnosis, your strongest advocate is yourself. Symptoms may vary widely among individuals, and for some, they may not even surface. Kyle, who is living with glioma, worked closely with his healthcare team to navigate his diagnosis and chart a path forward. Understanding the latest advancements and available resources in glioma management is key. Learn more: https://lnkd.in/gWZ8P7bM #CancerSurvivorsMonth